Research dossier
Clinical research on Choline
10 trials reviewed across 6 indications.
Strongest evidence
Fetal brain development
Mechanism
Choline is the substrate for fetal hippocampal neurogenesis and one-carbon methylation. Maternal stores are heavily drawn down in late pregnancy and during lactation — phosphatidylcholine is a major component of fetal cell membranes and myelin.
Caudill 2018 (n=26) found 930 mg/day vs 480 mg/day in pregnancy faster infant information-processing speed across the first year — even though both arms exceeded the AI. A companion trial (Lewis 2014) found no effect on infant short-term memory at 750 mg/day. Different domains, same direction of evidence: pregnancy choline matters, and current intake is too low.
Strongest evidence base for choline. Pregnant women — and especially egg-avoiders — are the population most likely to benefit from supplementation.
Trials cited
Maternal choline and infant information-processing speed
positive · RCT
Caudill et al., 2018, FASEB Journaln=26Cornell controlled-feeding RCT in 26 pregnant women. Infants of mothers consuming 930 mg/day choline had significantly faster information-processing speed across all four post-natal test points vs the 480 mg/day group — even though both groups exceeded the current AI of 450 mg/day.
Small sample (n=26). Suggests the current pregnancy AI may be set too low, but a larger pre-registered replication is still missing.
Higher maternal choline did not improve infant short-term memory
Null · RCT
Lewis et al., 2014, FASEB Journaln=99In a separate cohort of pregnant women, raising choline intake to 750 mg/day did not improve infant short-term visual memory or saccade planning vs the lower-intake control. Suggests the cognitive signal in Caudill 2018 may be specific to information-processing speed, not memory.
Different cognitive domain tested than Caudill 2018. The two trials are not direct contradictions — they look at different endpoints.
NHANES analysis of US choline intake
positive · Observational
Wallace and Fulgoni, 2017, Nutrientsn=14000NHANES data showed fewer than 11% of US adults — and only 8% of pregnant women — consume enough choline to meet the Adequate Intake. Eggs, beef liver, and dairy are the dominant food sources; egg avoidance drops intake further.
Observational intake data, not an intervention. Documents the gap without proving supplemental repletion delivers downstream clinical benefit.
Hepatic steatosis and fatty liver
Mechanism
Phosphatidylcholine is required for hepatic VLDL assembly — the lipoprotein that exports fat from the liver. Without enough choline, triglycerides back up in hepatocytes and steatosis develops. Estrogen induces PEMT (the de novo phosphatidylcholine synthesis pathway), which is why post-menopausal women lose this safety net.
Choline depletion reliably causes liver injury within weeks in controlled feeding (Fischer 2007, 2010). IV choline reverses TPN-associated steatosis (Buchman 1995). Cross-sectional data link low choline intake to worse NAFLD histology. No RCT shows oral choline supplementation reverses diet-driven NAFLD in free-living adults.
Strongest in frankly deficient states: long-term TPN, post-menopausal women on low-choline diets, PEMT/MTHFD1 risk genotypes. Not validated as an NAFLD treatment.
Choline deficiency causes hepatic and muscle injury
positive · RCT
Fischer et al., 2007, American Journal of Clinical Nutritionn=57Under controlled feeding, most healthy adults developed liver dysfunction (rising ALT and/or hepatic steatosis) and muscle damage within weeks of choline-deficient feeding. Repletion reversed organ injury. Establishes choline as a conditionally essential nutrient in humans.
Genetic variants (PEMT, MTHFD1) modify how quickly deficiency manifests — post-menopausal women and men were most susceptible. Free-living deficiency this severe is rare.
Choline requirement higher in postmenopausal women
positive · RCT
Fischer et al., 2010, American Journal of Clinical Nutritionn=80Postmenopausal women developed organ dysfunction during choline depletion far more readily than premenopausal women. Estrogen induces PEMT — the enzyme that lets the liver synthesize phosphatidylcholine from scratch — so post-menopause shifts choline from semi-essential to essential.
Controlled feeding; effect sizes in free-living adults consuming mixed Western diets are smaller.
Low choline intake associates with worse NAFLD
mixed · Observational
Guerrerio et al., 2012, American Journal of Clinical Nutritionn=664In the NASH CRN cohort, postmenopausal women with low choline intake had more advanced hepatic fibrosis on biopsy. The signal did not hold across all subgroups, and no RCT has shown that choline supplementation reverses biopsy-confirmed NAFLD.
Cross-sectional; reverse causation possible. Mechanism (PEMT-driven VLDL export of hepatic fat) is well-established but supplement-level RCTs in NAFLD are lacking.
Choline reverses TPN-associated hepatic steatosis
positive · RCT
Buchman et al., 1995, Hepatologyn=15In adults on long-term TPN — a population reliably depleted of choline — adding choline to the TPN solution reversed CT-imaged hepatic steatosis. Proves the mechanism in a frankly deficient population, but doesn't generalize to free-living adults with diet-driven NAFLD.
Tiny sample (n=15) in a unique population. Should not be cited as evidence that supplemental choline treats general-population fatty liver.
Repleting a widespread intake gap
Mechanism
Choline is required for cell-membrane phosphatidylcholine, neurotransmitter synthesis, methylation, and lipid transport. It is conditionally essential in humans — the body synthesizes some via PEMT but not enough to meet needs in most adults.
Fewer than 11% of US adults meet the Adequate Intake. The strongest case for choline supplementation is the same as for vitamin D or magnesium: not a magic effect, but closing a real intake gap. 250–500 mg/day from a phosphatidylcholine or bitartrate supplement covers the average shortfall.
Repletion benefit is plausible across most adults but most clearly justified in egg-avoiders, vegans, pregnant/lactating women, and post-menopausal women.
NHANES analysis of US choline intake
positive · Observational
Wallace and Fulgoni, 2017, Nutrientsn=14000NHANES data showed fewer than 11% of US adults — and only 8% of pregnant women — consume enough choline to meet the Adequate Intake. Eggs, beef liver, and dairy are the dominant food sources; egg avoidance drops intake further.
Observational intake data, not an intervention. Documents the gap without proving supplemental repletion delivers downstream clinical benefit.
Choline deficiency causes hepatic and muscle injury
positive · RCT
Fischer et al., 2007, American Journal of Clinical Nutritionn=57Under controlled feeding, most healthy adults developed liver dysfunction (rising ALT and/or hepatic steatosis) and muscle damage within weeks of choline-deficient feeding. Repletion reversed organ injury. Establishes choline as a conditionally essential nutrient in humans.
Genetic variants (PEMT, MTHFD1) modify how quickly deficiency manifests — post-menopausal women and men were most susceptible. Free-living deficiency this severe is rare.
Cognition and acetylcholine synthesis
Mechanism
Choline is the direct precursor to acetylcholine — the cholinergic system underwrites memory and attention. The popular argument is that supplemental choline raises acetylcholine synthesis; the trial evidence in healthy adults is weaker than the mechanism suggests.
Mechanism is sound, but the cognitive RCT base for generic choline (bitartrate, chloride, lecithin) in healthy adults is sparse and largely null. The cognitive trial evidence belongs to Alpha-GPC and citicoline — different molecules with their own bodies of evidence. Don't extrapolate from those to choline bitartrate.
No RCT has shown generic choline bitartrate or lecithin improves cognition in healthy non-deficient adults. The cognition story is an Alpha-GPC / citicoline story, not a choline-salts story.
Maternal choline and infant information-processing speed
positive · RCT
Caudill et al., 2018, FASEB Journaln=26Cornell controlled-feeding RCT in 26 pregnant women. Infants of mothers consuming 930 mg/day choline had significantly faster information-processing speed across all four post-natal test points vs the 480 mg/day group — even though both groups exceeded the current AI of 450 mg/day.
Small sample (n=26). Suggests the current pregnancy AI may be set too low, but a larger pre-registered replication is still missing.
Higher maternal choline did not improve infant short-term memory
Null · RCT
Lewis et al., 2014, FASEB Journaln=99In a separate cohort of pregnant women, raising choline intake to 750 mg/day did not improve infant short-term visual memory or saccade planning vs the lower-intake control. Suggests the cognitive signal in Caudill 2018 may be specific to information-processing speed, not memory.
Different cognitive domain tested than Caudill 2018. The two trials are not direct contradictions — they look at different endpoints.
Homocysteine and methylation
Mechanism
Choline donates methyl groups via betaine and the BHMT pathway, modestly lowering homocysteine. The complication: gut microbes convert excess dietary choline to TMA, which the liver oxidizes to TMAO — a metabolite associated with cardiovascular events in observational data.
Choline lowers homocysteine via betaine — modestly, and homocysteine-lowering has failed to reduce CV events in trials. Meanwhile, dietary choline raises TMAO, which observational data link to ~1.6× CV event risk. The honest read: cardiovascular effects of supplemental choline are net unclear, not net positive.
Do not supplement choline 'for the heart.' The TMAO question is genuinely unresolved and homocysteine lowering does not move cardiovascular endpoints.
Choline and betaine lower plasma homocysteine
mixed · Systematic review
Olthof and Verhoef, 2005, Current Drug Metabolism (review of dosing trials)Supplemental choline (via betaine pathway through BHMT) modestly lowers fasting homocysteine and blunts post-methionine-load homocysteine spikes. Effect size is real but smaller than B12 + folate repletion, and homocysteine-lowering has not translated into cardiovascular event reduction in large RCTs.
Homocysteine is a surrogate marker. Mendelian randomization and intervention trials (HOPE-2, VITATOPS) failed to link homocysteine lowering to fewer cardiovascular events.
Gut microbe TMAO pathway from dietary choline
mixed · Observational
Tang et al., 2013, NEJMn=4007Higher plasma TMAO — a gut-microbiome-derived metabolite of dietary choline, phosphatidylcholine, and carnitine — associated with higher 3-year cardiovascular event rates. Oral phosphatidylcholine challenge raised TMAO in human volunteers. Established the choline-TMAO-CVD hypothesis.
Association, not causation. TMAO is also raised by fish (high baseline TMAO), and Mendelian randomization data for TMAO and CVD remain mixed. The clinical translation of the choline-TMAO link is unsettled.
TMAO and cardiovascular mortality (meta-analysis)
mixed · Meta-analysis
Schiattarella et al., 2017 / Heianza et al., 2022 (pooled meta-analyses)Meta-analyses link higher TMAO to ~1.6× cardiovascular event risk and higher all-cause mortality. The relationship is dose-dependent in observational data — but no interventional trial has shown that lowering TMAO via choline restriction (or otherwise) reduces hard cardiovascular endpoints.
Confounding by red meat and L-carnitine intake (also TMAO precursors) is hard to eliminate. The choline-specific causal contribution is unclear.
Lipid metabolism and VLDL export
Mechanism
Phosphatidylcholine is mandatory for VLDL assembly. Without enough, hepatic triglycerides cannot be packaged and exported — they accumulate as steatosis. This is the same pathway that links choline to fatty liver.
Deficiency disrupts VLDL export and drives hepatic fat accumulation. Repletion in deficient states restores normal lipid handling. In well-fed adults consuming average diets, supplemental choline produces no measurable improvement in lipid panels.
Meaningful effect in deficient states only. Do not expect choline to improve LDL, HDL, or triglycerides in adults with already-adequate intake.
Choline deficiency causes hepatic and muscle injury
positive · RCT
Fischer et al., 2007, American Journal of Clinical Nutritionn=57Under controlled feeding, most healthy adults developed liver dysfunction (rising ALT and/or hepatic steatosis) and muscle damage within weeks of choline-deficient feeding. Repletion reversed organ injury. Establishes choline as a conditionally essential nutrient in humans.
Genetic variants (PEMT, MTHFD1) modify how quickly deficiency manifests — post-menopausal women and men were most susceptible. Free-living deficiency this severe is rare.
Low choline intake associates with worse NAFLD
mixed · Observational
Guerrerio et al., 2012, American Journal of Clinical Nutritionn=664In the NASH CRN cohort, postmenopausal women with low choline intake had more advanced hepatic fibrosis on biopsy. The signal did not hold across all subgroups, and no RCT has shown that choline supplementation reverses biopsy-confirmed NAFLD.
Cross-sectional; reverse causation possible. Mechanism (PEMT-driven VLDL export of hepatic fat) is well-established but supplement-level RCTs in NAFLD are lacking.
4 forms of Choline compared
VitaCholine®
Choline bitartrate
~41% choline by weight; raises plasma choline modestly, poor brain penetration
Best forCheap repletion of dietary intake gapThe default form in most multivitamins. Adequate for closing the dietary AI gap but does not raise brain choline meaningfully — don't expect cognitive benefit from this form.
Choline chloride
~75% choline by weight; well-absorbed but low brain bioavailability
Best forRepletion; the form used in the TPN steatosis-reversal RCTHigh elemental choline content per gram. Higher doses can cause fishy body odor as gut microbes convert excess choline to trimethylamine.
Phosphatidylcholine
~13% choline by weight, but raises plasma choline gradually with a gentler GI profile than salt forms
Best forGeneral repletion, especially when GI tolerance of bitartrate or chloride is an issueThe membrane-phospholipid form — the same form choline takes in the body. Usually sourced from sunflower or soy lecithin. Lower elemental dose per capsule but well-tolerated.
Lecithin (sunflower or soy)
Mixed phospholipids; phosphatidylcholine fraction ~13–35% depending on source — cheapest source of elemental choline
Best forInexpensive dietary phosphatidylcholine supplementationVariable phosphatidylcholine content across brands. Sunflower lecithin avoids the soy and GMO concerns of soy-derived lecithin. Per-capsule elemental choline is low — read the label.
Are you deficient? Symptoms, risk groups, lab tests
Fewer than 11% of US adults — and only ~8% of pregnant women — consume the Adequate Intake for choline (Wallace & Fulgoni, NHANES 2017). Egg avoidance, vegan diets, and ultra-processed-food intake all worsen the gap.
Common symptoms
- Fatty liver and elevated liver enzymes (ALT/AST) under controlled depletion
- Muscle damage with elevated creatine kinase under severe depletion
- Persistent fatigue and poor exercise recovery
- Memory or attention complaints in older adults (mechanistically plausible; not RCT-validated)
- Adverse pregnancy outcomes including neural tube defects when stacked with low folate
- Hyperhomocysteinemia (when combined with low B12 and folate)
Who is at risk
Pregnant and lactating women
Fetal demand draws heavily on maternal stores in the third trimester and during lactation. The AI rises to 450 mg/day in pregnancy and 550 mg/day during lactation — most pregnant women fall well below.
Post-menopausal women
Estrogen induces PEMT, the enzyme that lets the liver synthesize phosphatidylcholine de novo. Post-menopause, that safety net is gone and dietary choline becomes more essential. Fischer 2010 showed post-menopausal women develop organ injury faster under depletion.
Vegans and egg-avoiders
Eggs, beef liver, and dairy dominate dietary choline. Removing them without deliberate substitution drops intake well below the AI.
Adults with PEMT or MTHFD1 risk variants
Common single-nucleotide polymorphisms in PEMT (rs12325817) and MTHFD1 (rs2236225) accelerate organ injury under low-choline conditions. These adults need closer to the upper end of the recommended range.
Adults on long-term total parenteral nutrition (TPN)
Most commercial TPN formulations contain little or no choline, reliably producing hepatic steatosis over time. Choline supplementation (oral or IV) is part of long-term TPN management.
Adults with NAFLD or insulin resistance
NAFLD patients show lower dietary choline intake and lower plasma choline. Whether supplementation alters NAFLD course in free-living adults is not yet RCT-proven.
Heavy alcohol users
Alcohol disrupts phosphatidylcholine metabolism and increases hepatic demand. Combined with the typical alcohol-heavy diet pattern, this stacks deficiency risk.
Lab markers
Plasma free choline
Plasma choline is tightly regulated — values stay near-normal until severe depletion. A normal plasma choline does not rule out functional insufficiency. Most clinical labs do not offer this test.
Better:Plasma phosphatidylcholine, Plasma betaine, ALT (as downstream marker of choline-deficient hepatic injury)
- Typical adult reference range
- 7–20 µmol/L
Side effects and drug interactions
Side effects
Fishy body odor
Common · Becomes likely above ~2–3 g/day; some individuals (FMO3 variants) experience it at lower doses
Gut microbes convert excess choline to trimethylamine, which the body releases through sweat and breath. Genuinely socially disabling at high supplemental doses; benign physiologically.
Worse with:choline chloride, choline bitartrate
Gentler:phosphatidylcholine, lecithin
GI distress and nausea
Common · Typically above 1–2 g/day of salt forms
Bitartrate and chloride salts can cause nausea, vomiting, and loose stools at higher doses. The salt form irritates more than phospholipid forms.
Worse with:choline bitartrate, choline chloride
Gentler:phosphatidylcholine, lecithin
Hypotension and sweating
Uncommon · Reported above ~7.5 g/day; the IOM Upper Limit is 3.5 g/day for this reason
Very high doses can produce cholinomimetic effects — low blood pressure, sweating, salivation — via systemic acetylcholine elevation.
Body odor in primary trimethylaminuria (TMAU)
Rare
Adults with the genetic disorder trimethylaminuria cannot oxidize TMA. High-choline supplements (or even high-choline diets) can produce severe persistent fish odor.
Possible elevated TMAO and cardiovascular concern
Uncommon
Supplemental choline raises plasma TMAO in dose-dependent fashion. Observational data link higher TMAO to cardiovascular events; interventional proof of harm or benefit is missing. Treat as an open question, not a settled risk.
Worse with:choline bitartrate, choline chloride, phosphatidylcholine, lecithin
Drug interactions
Reduces nutrient status
methotrexateMethotrexate inhibits the folate-dependent methylation pathway that interacts with choline metabolism. Long-term methotrexate may increase choline requirements.
Coordinate with prescriber. Standard repletion doses (250–500 mg/day) are usually fine; supraphysiological dosing should be discussed.
Other
anticholinergic medications (e.g. oxybutynin, diphenhydramine, scopolamine, tricyclic antidepressants)Supplemental choline raises acetylcholine substrate availability; theoretically antagonistic to anticholinergic drug effects, though clinical interactions at typical supplement doses are rarely reported.
Not a hard contraindication. Watch for blunted effect of the prescribed anticholinergic if supplementing at the high end.
Additive effect
cholinergic drugs (e.g. donepezil, rivastigmine, galantamine, pilocarpine)Additive cholinergic tone — supplemental choline raises acetylcholine substrate while cholinesterase inhibitors block its breakdown.
Discuss with the prescribing clinician. Likely tolerated at low doses but the combination can amplify GI cholinergic side effects.
Other critical caveats
- Do not extrapolate Alpha-GPC or CDP-choline (citicoline) cognitive RCT data to choline bitartrate, chloride, lecithin, or phosphatidylcholine. Those are different molecules with different brain pharmacokinetics. Generic choline-salts do not have a robust cognitive RCT base in healthy adults.
- The choline → gut microbiome → TMAO → cardiovascular event signal is real in observational data and Mendelian randomization is mixed. Anyone supplementing choline 'for the heart' is operating against the published direction of risk, not for it.
- Stay under the 3.5 g/day Upper Limit. Hypotension, sweating, and fishy body odor become likely at higher chronic doses. The Upper Limit applies to total supplemental choline, not dietary intake.
- Pregnancy AI is 450 mg/day and lactation AI is 550 mg/day. Most pregnant women fall short. Discuss choline supplementation with the prescribing OB before adding it to a prenatal that may already contain some.
Frequently asked
What's the best form of choline to take?
Depends on the goal. For closing a dietary intake gap, choline bitartrate (cheap, ~41% choline by weight) or phosphatidylcholine (gentler GI profile, slower release) both work. For cognition, the trial evidence belongs to Alpha-GPC and CDP-choline (citicoline) — those are different molecules with their own pages. Don't expect choline bitartrate to do what Alpha-GPC does.How much choline should I take?
The Adequate Intake is 425 mg/day for women, 550 mg/day for men, 450 mg/day in pregnancy, and 550 mg/day during lactation. Most US adults consume less. Typical supplement doses run 250–500 mg/day; the FDA Upper Limit is 3,500 mg/day. Pregnant women on low-choline diets are the population with the strongest evidence-based case for supplementation.Will choline make me smarter?
Not from choline bitartrate or lecithin. The cognition trials that get cited — Bellar 2015 for power output, Italian dementia trials for memory — used Alpha-GPC or CDP-choline (citicoline), not generic choline. Those are different supplements with their own evidence base. Treat 'choline for cognition' as Alpha-GPC marketing-by-association.Is choline safe in pregnancy?
Yes, and arguably under-supplemented. The pregnancy AI is 450 mg/day; most pregnant women fall well below. Caudill 2018 used 480 mg/day vs 930 mg/day and found infant cognitive benefit at the higher dose. The Upper Limit is 3.5 g/day. Coordinate with your OB — many prenatal vitamins now include 50–100 mg of choline, but that's a fraction of the AI.Will choline cause fishy body odor?
It can. Above roughly 2–3 g/day, gut microbes convert excess choline to trimethylamine, which the body releases through sweat and breath. Phosphatidylcholine and lecithin are less likely to trigger this than choline chloride or bitartrate. People with the genetic disorder trimethylaminuria (TMAU) can experience this at much lower doses.Is choline bad for the heart because of TMAO?
Honest answer: unclear. Supplemental choline raises plasma TMAO, and TMAO is associated with cardiovascular events in observational meta-analyses. But no interventional trial has shown that lowering TMAO reduces cardiovascular events, and red meat / L-carnitine are also TMAO precursors. The choline-specific causal contribution to CVD is unresolved.Do I need a choline supplement if I eat eggs?
Probably not. Two large eggs contain ~290 mg of choline — within striking distance of the AI for women and a meaningful contribution for men. Adults who eat eggs, dairy, and meat regularly often hit the AI from diet. Vegans, egg-avoiders, and pregnant women have the strongest case for a supplement.
References
- 01NIH Office of Dietary Supplements — Choline Health Professional Fact Sheet
- 02StatPearls — Choline (NCBI Bookshelf)
- 03Wallace and Fulgoni, 2017, Nutrients — Usual Choline Intakes Are Below Recommended Adequate Intakes
- 04Caudill et al., 2018, FASEB Journal — Maternal choline supplementation during pregnancy improves infant information processing speed
Last reviewed2026-05-22